Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCPAIN: Modality Choice for Painful Diabetic Neuropathy
NCT07795593Phase 4Not yet recruiting
- Sponsor
- University of Michigan
- Start
- Nov 2026
- Primary completion
- May 2031
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in diabetic neuropathy (12 arms), sponsored by University of Michigan. Primary endpoint: Patient-centered utility function at 8 months. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT07795593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07795593.